INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG ..
IASLC 2026 World Conference on Lung CancerSeptember 12–15, 2026 Seoul
N. Poster
Poster title
Applicant name
Status
 |
|
|
|
| 7-PT1 | ARIAN, a Phase III, Randomized Study of Adjuvant Treatment With Sacituzumab and Zimberelimab in Resected Patients | María Fernández |  Received |
 |
|||
| 17-P1 | Bridging the Treatment Gap: Prospective Cardiovascular Prevention in the ARIA Lung Cancer Screening Program | Piergiorgio Muriana | Received |
|
|||
| 23-P2 | Fulzerasib in Combination With Omeprazole Pretreatment and/or Terbinafine in KRAS G12C Mutant Lung Cancer Cell Lines | Rafael Rosell | Received |
|
|||
| 187-P3 | Treatment Sequences and Outcomes in Patients With ALK/ROS1 Advanced Non-Small Cell Lung Cancer: A Nationwide Cohort Study | Adrien Rousseau | Received |
|
|||
| 188-P3 | Treatment Sequences and Outcomes in Patients With BRAF Advanced Non-Small Cell Lung Cancer: A Nationwide Cohort Study | Adrien Rousseau | Received |
|
|||
| 199-P1 | Persistent N2 After Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer: Insights From Three Prospective Cohorts | María Fernández | Received |
|
|||
| 226-P3 | Real-World Outcomes of Lazertinib as a First-Line Monotherapy in EGFR-mutated Advanced NSCLC | Jii Bum Lee | Received |
|
|||
| 309-P1 | Causes and Patterns of Mortality After Surgery in Patients With Non-Small Cell Lung Cancer: A Retrospective Study | María Fernández | Received |
|
|||
| 310-P1 | Excess Mortality After Curative Surgery for Non-Small Cell Lung Cancer: A Population-Based Analysis of Long-Term Survivorship | María Fernández | Received |
|
|||
| 360-P1 | Not All Patients Are Equal: Disparities in Access to Precision Oncology for Advanced NSCLC in Brazil | Marcos Aurelio Fonseca Magalhaes Filho | Received |
|
|||
| 366-P2 | ALPACCA: Ph3 Trial of Firmonertinib vs Investigator´s Choice of EGFRI as 1L Treatment for Locally Advanced or mNSLC With EGFR PACC Mutations | John Le | Received |
|
|||
| 366-P1 | Who Needs Another Podcast? You Do! Creating the Coping With Lung Cancer Podcast | Maureen Rigney | Received |
|
|||
| 385-P2 | ATHENEA, a Phase II Study of Atezolizumab as Neoadjuvant, Adjuvant and Maintenance Treatment for Stage IIIA-IIIB NSCLC Patients | María Fernández | Received |
|
|||
| 386-P2 | MERLIN, Tarlatamab Treatment for Limited Small Cell Lung Cancer in Patients in Maintenance: A Phase II Clinical Trial | María Fernández | Received |
|
|||
| 388-P2 | PALACE, Cemiplimab Trial According to ctDNA Levels: A Phase II Clinical Trial | María Fernández | Received |
|
|||
IASLC 2026 World Conference on Lung Cancer
September 12–15, 2026 Seoul
Search and consult posters online
in an exclusive section
for each poster
in an exclusive section
for each poster
ACTIVE FROM 12/09/2026 TO 12/09/2026
Poster
Gallery
Gallery
Upload
Poster
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
Forum
|
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress.
|
|
||
|
||||
Poster submission deadline 24/08/2026
|
|
